Начало › Колоректален рак › Мериленд › Baltimore
Клинични проучвания за Колоректален рак в Baltimore, MD
31 проучвания за Колоректален рак търсят участници в обекти в и около Baltimore (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Family Communications After Genetic Testing
Набиране на участнициЗдравите доброволци са добре дошли
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · на 8 мили
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- и още 2
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Набиране на участнициФаза 1
- Exelixis Clinical Site #14, Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- Greater Baltimore Medical Center, Baltimore
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Набиране на участнициФаза 3
- MedStar Franklin Square Medical Center, Baltimore
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Набиране на участнициФаза 3
- MedStar Franklin Square Medical Center, Baltimore
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Набиране на участнициФаза 2/3
- Local Institution - 0262, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Набиране на участнициФаза 1
- United Theranostics, Glen Burnie · на 9 мили
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Набиране на участнициФаза 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Набиране на участнициФаза 1
- Johns Hopkins, Baltimore
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Набиране на участнициФаза 3
- Saint Agnes Hospital, Baltimore
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
Набиране на участнициФаза 1
- United Theranostics, Glen Burnie · на 9 мили
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Набиране на участнициФаза 1/2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- Clinical Study Site, Baltimore
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Набиране на участнициФаза 2
- Research Site, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Набиране на участнициФаза 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Набиране на участнициФаза 1
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Набиране на участнициФаза 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
Набиране на участнициФаза 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Набиране на участнициФаза 2
- Johns Hopkins Hospital /ID# 275645, Baltimore
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Набиране на участнициФаза 4
- Mercy Medical Center, Baltimore
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Набиране на участници
- Johns Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Набиране на участнициФаза 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · на 9 мили
- United Theranostics - Chesapeake, Glen Burnie · на 9 мили
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набиране на участнициФаза 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- Johns Hopkins Hospital, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Набиране на участнициФаза 1/2
- Johns Hopkins University, Baltimore
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Набиране на участнициФаза 2
- Johns Hopkins SKCCC, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Johns Hopkins University, Baltimore
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Набиране на участнициФаза 2
- NGM Clinical Study Site, Baltimore
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набиране на участнициНаблюдателно проучване
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · на 8 мили
- и още 1
Проучвания за Колоректален рак в други градове
- Houston, TX102 проучвания
- New York City, NY78 проучвания
- Nashville, TN69 проучвания
- Boston, MA63 проучвания
- Los Angeles, CA59 проучвания
- Arlington, VA52 проучвания
- St. Louis, MO50 проучвания
- San Antonio, TX46 проучвания
- Philadelphia, PA44 проучвания
- Grand Rapids, MI40 проучвания
- Baldwin Park, CA37 проучвания
- Chicago, IL34 проучвания
Други проучвания в Baltimore
- Рак на белия дроб с недребноклетъчен тип60 проучвания
- Рак на гърдата47 проучвания
- Рак на простатата43 проучвания
- Рак на белия дроб40 проучвания
- Рак (всички видове)37 проучвания
- Рак на панкреаса31 проучвания
- Метастатичен рак28 проучвания
- Затлъстяване26 проучвания
- Рак на пикочния мехур24 проучвания
- Сърдечна недостатъчност24 проучвания
- Рак на яйчниците22 проучвания
- Инсульт21 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.